Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphoma.
Miyabi SaitoNolan A WagesDavid SchiffPublished in: Journal of neuro-oncology (2021)
Patients with PCNSL are at high risk of VTE, most of which accrues in the first few months. History of VTE, diabetes mellitus (type 1 or 2), impaired ambulatory status, or hemoglobin < 10 g/dL may predispose patients to this complication. While optimal management is uncertain, anticoagulation prevented recurrent VTE in most patients without intracranial bleeding.